Enanta Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €73.74M +26.3% -€76.65M +15.7% -103.9% +0.095 pp N/A N/A
    (estimated) €58.40M +1.9% -€66.23M -3.5% -113.4% +0.063 pp N/A N/A
    (estimated) €57.32M +2.7% -€68.63M -7.4% -119.7% +0.13 pp N/A N/A
    (estimated) €55.80M -1.4% -€74.11M -2.5% -132.8% +0.015 pp N/A N/A
    (estimated) €56.60M -1.9% -€76.04M -23.2% -134.3% +0.37 pp N/A N/A
    €57.69M -14.6% -€98.98M -13.3% -171.6% -0.026 pp -€51.87M -35.4% -89.9% +0.29 pp
    €67.56M -8.1% -€114.14M +9.9% -169.0% -0.28 pp -€80.26M +13.8% -118.8% -0.23 pp
    €73.49M -11.2% -€103.85M +54.1% -141.3% -0.60 pp -€70.50M +19.4% -95.9% -0.25 pp
    €82.80M -20.7% -€67.38M +118.4% -81.4% -0.52 pp -€59.06M -911.5% -71.3% -0.78 pp
    €104.46M -40.3% -€30.85M -178.0% -29.5% -0.52 pp €7.28M -88.9% 7.0% -0.30 pp
    €175.02M -0.7% €39.56M -35.5% 22.6% -0.12 pp €65.54M +138.6% 37.4% +0.22 pp
    €176.24M +101.0% €61.37M +306.3% 34.8% +0.18 pp €27.47M -41.6% 15.6% -0.38 pp
    €87.70M +16.5% €15.11M -18.3% 17.2% -0.073 pp €47.05M +36.0% 53.6% +0.077 pp
    €75.29M -45.1% €18.48M -72.6% 24.5% -0.25 pp €34.58M -48.7% 45.9% -0.032 pp
    €137.22M +237.0% €67.38M +129.4% 49.1% -0.23 pp €67.39M +272.6% 49.1% +0.047 pp
    €40.72M +48.9% €29.37M +257.7% 72.1% +0.42 pp €18.09M +88.4% 44.4% +0.093 pp
    €27.34M -23.1% €8.21M -55.0% 30.0% -0.21 pp €9.60M -50.8% 35.1% -0.20 pp
    €35.57M -0.4% €18.25M -8.2% 51.3% -0.043 pp €19.51M -6.5% 54.8% -0.036 pp
    €35.72M €19.88M 55.7% €20.87M 58.4%

    Notifications